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1. Introduction 
1.1 Definition of the disease 
Osteomyelitis (OM) is a true bacterial infection associated with inflammation of 
the bone marrow, the overlying cortical plates and periosteum. The infection can be 
limited to a localised section of the bone or can involve several different regions such as 
the bone marrow, cortex, periosteum or even extend to the surrounding soft tissue 
(Harik & Smeltzer, 2010). The clinical term osteomyelitis is derived from Greek, with 
osteon meaning bone, myelos standing for marrow, and itis, a suffix used in 
pathological terms indicating an infection of a specific part of the body (Malhotra, 
Chan, & Nather, 2014). 
Osteomyelitis of the jaw can be distinguished from long bone osteomyelitis in 
several important ways, mainly due to its specific features where the bone of the jaw is 
connected to the oral cavity, teeth and periodontal membrane (M. M. Baltensperger, 
Eyrich, & SpringerLink (Online service), 2009). During the course of the disease, the 
affected bone does not heal and remains exposed in the mouth even after appropriate 
intervention (Reid, 2009). 
Albeit the improvements in dental care, osteomyelitis of the jaw is still considered 
one of the most challenging problems for dental clinicians and maxillofacial surgeons. 
The introduction of antibiotics in the twentieth century has decreased the risk of 
acquiring the disease and its complications significantly (Hudson, 1993; Goda, 
Maruyama, Michi, Nakagawa, and Harada (2014); (Lu et al., 2016).  
The patient’s history, clinical and radiological examinations as well as 
intraoperative findings are the cornerstones for diagnosing OM (Nezafati, Ghavimi, & 
Yavari, 2009). Histological and microbiological tests also play a major role 
(Dimitrakopoulos, Magopoulos, & Katopodi, 2007; Senel, Jessen, Melo, & Obeid, 
2007). Radiation, malignancy, osteoporosis and other factors impairing blood supply or 
inducing necrosis by altering the bone vascularity are considered predisposing factors of 
the disease. Diabetes may have a serious influence on the course of OM as it alters the 
host defence mechanisms (Topazian & Binder, 1994). Medications most commonly 
associated with OM are steroids and chemotherapeutic agents (Esenyel et al., 2007; 
Reid & Cundy, 2009; Yavuz, Kaya, Yalcin, & Aras, 2008). 
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1.2 Classification of osteomyelitis 
From a practical point of view, distinction of the different types of osteomyelitis 
is useful (Kwon, Choi, Ahn, & An, 2013; Lew & Waldvogel, 2004). Baltensperger and 
Eyrich reviewed osteomyelitis of the jaw in the literature and differentiated precisely 
between many classifications of the OM based on clinical pictures, aetiology, radiology, 
pathogenesis, pathological anatomy, and pathophysiology (M. M. Baltensperger et al., 
2009). There are numerous suggested classification systems of OM in the literature, 
which has led to the absence of an international consensus nomenclature and confusion 
regarding the results of comparative studies. 
One of the important classifications divides OM into bacterial osteomyelitis (B-
OM), including acute, chronic suppurative and secondary chronic OM caused by 
bacterial odontogenic infection or haematogenous spread, and non-bacterial 
osteomyelitis (NB-OM), which is used as an umbrella term describing non-infectious 
inflammatory bone disorders where the cause remains unidentified. NB-OM includes 
diffuse sclerosing osteomyelitis (DSO), chronic recurrent multifocal osteomyelitis 
(CRMO), primary chronic OM, sclerosing non-suppurative OM and SAPHO (synovitis, 
acne, pustulosis, hyperosteitis and osteitis) syndrome (Suei, Taguchi, & Tanimoto, 
2005) (Supplementary Table 1). 
1.3 Aetiology of the disease 
1.3.1 Bacterial osteomyelitis (B-OM) 
Bacterial osteomyelitis of the jaw is caused by infections derived from a wide 
range of microorganisms such as bacteria, mycobacteria, fungi, viruses and parasites 
(Gabrielli et al., 2014). The most common bacterial organism responsible is 
Staphylococcus aureus, followed by haemolytic streptococcus, pneumococcus, 
Escherichia coli, and Proteus species. An infection caused by two or more of these 
bacteria has also been well documented (Sun, Xue, Wu, & Zhou, 2017). 
The presence of teeth plays a vital role in the disease aetiology by providing the 
bacteria with a direct pathway to the bone, this invasion of the bone in turn causes the 
development of osteomyelitis. This leads to pervasive inflammation, necrosis and bone 
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destruction at the sites of infection. Smoking, diabetes, anaemia, malnutrition, 
malignancies, immunocompromised status as well as other systemic factors causing 
bone hypovascularity can predispose to OM (Baur, Altay, Flores-Hidalgo, Ort, & 
Quereshy, 2015; Ehrenfeld, 2000; Kwon et al., 2013; Lu et al., 2016; Rosenberg & 
Khurana, 2016; Sun, Xue, Wu, & Zhou, 2016). Avital and impacted teeth as well as 
periodontal diseases have been implicated as possible OM triggering factors (Calhoun, 
Shapiro, Stiernberg, Calhoun, & Mader, 1988; Koorbusch, Fotos, & Goll, 1992; 
Neumann, Steinbrecher, & Thimann, 1975). It was also observed that the bacteraemia 
occurring after extractions and mucogingival procedures plays a role in the pathogenesis 
of the acute OM (Otten, 1987). 
Osteoradionecrosis, or radioosteomyelitis, is a special form of bacterial 
osteomyelitis (R. E. Marx, 1983) in which irradiation of the bone leads to the formation 
of transcribed necrosis. Vascular damage causing bone hypovascularity has been 
implicated as the aetiology behind this entity (Ehrenfeld, 2000; Robert E. Marx & 
Ames, 1982). In addition, during fixation and open reduction of bone fragments, when 
the fracture edges are not stabilised against each other, in combination with the above 
mentioned reduced systemic factors may result in the development of a specific type of 
bacterial osteomyelitis called trauma/fracture-related acute osteomyelitis (in German: 
Bruchspaltosteomyelitis). This type of OM sometimes occurs after orthognathic 
surgeries, and the reported infection rate in these cases is up to 17.5% ( Düker, 2000). 
Furthermore, the risk of infection during intra-oral operations and osteotomies due to 
saliva contamination is always present.  
Bacterial osteomyelitis is divided into acute and chronic forms (Zimmerli & 
Fluckiger, 2004). The acute form of bacterial osteomyelitis is differentiated from the 
chronic form by its rapid onset, usually the infection is diagnosed within two weeks 
after initiation of the disease and it is usually highly acute. When the diagnosis persists 
for more than two weeks after the appearance of symptoms the sub-acute type will be 
diagnosed (Bohndorf, 2004). The term secondary chronic osteomyelitis refers to when 
the complaint lasts for several months after the acute form, the transition from the sub-
acute to the chronic form is smooth, with no clear separation between the two phases 
Introduction 8 
 
 
(Harik & Smeltzer, 2010; Lew & Waldvogel, 2004). The chronic form of osteomyelitis 
is classified based on the aetiology into two forms:  
- Exogenous chronic osteomyelitis in which mandibular exogenous chronic 
osteomyelitis, occurring after an extended infection from a nearby soft or hard tissue 
(Loh & Ling, 1993), can be differentiated from the exogenous chronic osteomyelitis 
of the long bone, happening post-trauma or post-operatively. 
-  Endogenous chronic osteomyelitis involving haematogenous infection (Bass, 1928; 
Engel, 1939; Heslop, 1956; Lacey, 1929; Nade, 1983; Rowe, 1956). 
The transition from acute to chronic haematogenous OM occurs due to reduced 
immunity or inadequate treatment of the acute phase (Bohndorf, 2004). This type of 
OM is very rare and occurs only in infants and young children in the form of infantile 
osteomyelitis (Graswinckel, Marti, & Besselaar, 1988).  
1.3.2 Non-bacterial osteomyelitis (NB-OM) 
Another clinical entity of the so-called osteomyelitis is diffuse sclerosing 
osteomyelitis (DSO), a chronic non-bacterial disease with low grade infection and 
unknown aetiology (Hino, Murase, Terakado, Shintani, & Hamakawa, 2005; Otto et al., 
2015), exclusively affecting the mandible. The aetiology and pathogenesis of DSO remain 
controversial. Many studies in the literature believe it is a response to a microbial stimulus 
of low virulent bacteria (M. Baltensperger et al., 2004; Eyrich, Baltensperger, Bruder, & 
Graetz, 2003; Eyrich et al., 1999; Eyrich, Langenegger, Bruder, Sailer, & Michel, 2000), 
but a specific microbiome has not been identified (Montonen & Lindqvist, 2003). 
Some authors support the hypothesis of an autoimmune process causing the 
disease (Khanna, Sato, & Ferguson, 2009) and that the inflammatory response could be 
due to a hyperactive immunologic reaction to the bacterial toxins (Kuijpers, de Jong, 
Hamdy, & van Merkesteyn, 2011; Montonen, Kalso, Pylkkaren, Lindstrorm, & 
Lindqvist, 2001; Montonen & Lindqvist, 2003). Others have introduced chronic 
periostitis as a new concept of its aetiology. Furthermore, it has been also suggested that 
DSO is due to chronic muscular hyperactivity (van de Meent et al., 2017). 
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1.4 Histopathology of osteomyelitis  
1.4.1 Bacterial osteomyelitis (B-OM) 
Many  microscopic as well as macroscopic changes occur throughout the various 
stages of osteomyelitis. An increase in the intramedullary pressure causes the death of the 
central soft tissue, with the pus-forming infection spreading through the bone marrow and 
the canals. Septic thrombosis causes irreversible ischemic damage to the osteocytes and 
osteoclasts, leading to necrosis of large parts of bone and prevention of bone remodelling. 
The formation of granulation tissue in addition to the increase in osteoclastic activity, 
occurring at the border between the dead and still viable bone, causes the detachment of 
the necrotic sequester, which in turn lies loosely in the centre. A surrounding zone of 
fibrotic and reactive bone layer coats the granulation tissue, completely walling off the 
necrotic infective part. If this thickened new bone fails to compartmentalise the infection, 
dissemination through the whole bone marrow and even an extramedullary spread may 
occur. This leads to the periosteum reacting with the newly formed bone around outbreak 
areas. The immune defence reaction depends on the general status of the  immune system 
as well as that of the blood vessels (Ehrenfeld, 2000). 
A biopsy can be used to verify the histopathological findings. In the case of acute 
osteomyelitis, necrotic bone tissue with osteocyte loss, peripheral resorption, bacterial 
colonisation, and infiltration of polymorphic leukocytes, a sign of acute inflammation, 
are the main features (Schimming, 2003). In chronic osteomyelitis, there is evidence of 
resorptive, necrotising as well as regenerative bone processes (Evers, 1978; Sitzmann, 
2003a). Nonetheless, differentiation of chronic osteomyelitis according to the histology 
alone is not enough, rather acknowledgement of all findings including follow-up is 
necessary to reach a correct diagnosis (Ehrenfeld, 2000). 
1.4.2 Non-bacterial osteomyelitis (NB-OM) 
Histological biopsy results demonstrate a non-specific chronic inflammation, indicated 
mainly by infiltration of plasma cells, with varying amounts of neutrophils, lymphocytes, and 
macrophages (M. Baltensperger et al., 2004; Frid, Tornes, Nielsen, & Skaug, 2009). 
Medullary fibrosis is the most common characteritstics of advance disease along with 
endosteal bone apposition with pagetoid (irregular of reversal lines) reaction. These findings 
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are also frequent in elderly patients. The development of subperiosteal bone and absorbtion of 
the bone are more prominent in early stages of the disease and in younger patients (M. 
Baltensperger et al., 2004). Although further studies are needed, increased accuracy can be 
achieved by extra-oral sampling or polymerase chain reaction (PCR) (Frid et al., 2009). 
1.5 Diagnosis  
1.5.1 Medical history 
The medical history or anamnesis should be attained by asking exact questions, 
with the aim of gaining information helpful in achieving a diagnosis or a provisional 
diagnosis of the disease.  
1.5.2 Clinical signs and symptoms 
These include intra and extra-oral examination, such as inspection, palpation, 
nerve sensibility tests and teeth vitality tests.  
Bacterial osteomyelitis (B-OM) 
Osteomyelitis of the jaw is one of the most difficult inflammatory diseases in the 
head and neck region, the earlier it is diagnosed, the easier it is to treat with less 
complications, but diagnosis in early stages is challenging because it differs depending 
on the level of infection, localisation of the disease, patients’ resistance and age 
(Karmazyn, 2010). 
Acute bacterial osteomyelitis is characterised by the classical symptoms of 
infection, like impairment of general conditions, severe pain, fever, swelling, redness 
and warmth at the affected site, and may show a suppurative course with abscess, as 
well as cervical lymphadenopathy with a moderate risk of sepsis which is associated 
with elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and 
pronounced leucocytosis (De Boeck, 2005; A. F. Jansson et al., 2009). Halitosis can 
occur caused by anaerobic bacteria, tooth mobility, leading to malocclusion (AWMF-
Leitlinien, 2002). Usually acute bacterial OM resolves completely with adequate 
treatment, but sometimes due to inadequate antibiotic regime, it can transform into 
chronic osteomyelitis (Harik & Smeltzer, 2010). 
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A clinical presentation similar to acute bacterial OM is usually witnessed with 
chronic bacterial osteomyelitis, although it remains remarkably milder and often 
associated with recurrent pain and swelling without the manifestations of the acute 
infection. Chronic B-OM is characterised by exposed necrotic bone with sequester 
formation, tooth mobility, fistula formation with pus discharging through the gingival 
sockets, and when the mandible is also involved, hypoesthesia of the lower lip 
(Vincent´s symptom) and trismus may also develop (Sasaki & Nameta, 1994). Fistula 
formation and the attempt to drain the accumulated exudate through it, is a well-known 
feature of the chronic phases of any infection. If the fistula becomes obstructed or any 
obstacle arises hindering the draining of exudate, fever and elevation of inflammatory 
parameters will be observed, similar to the acute phase (Schilli, 1988; Schimming, 
2003). Limited jaw function due to inflammation of temporomandibular joint and/or 
infection of the masticatory muscles could also occur. Pathological fracture of the jaw is 
expected in bacterial OM, arising due to resorption or surgical removal of necrotised 
tissue, which will then be replaced by granulation tissue, weakening the bone (Schilli, 
1988). 
Non-bacterial osteomyelitis (NB-OM) 
Primary chronic osteomyelitis, diffuse sclerosing osteomyelitis, as well as other 
types of non-bacterial OM, can remain clinically silent in the early stages of disease. 
Later, and in some active episodes of the disease, pain, swelling of the soft tissue, bone 
deformities as well as some of the features of the B-OM can develop (Schimming, 
2003). In the symptomatic period, blood tests usually reveal normal values of 
leukocytes, ESR and CRP, while the asymptomatic period can sometimes be associated 
with elevated levels of these parameters. For this reason, a diagnosis of a non-bacterial 
osteomyelitis should not depend on the blood results (Schmailzl, 1995). Recurrence of 
symptoms is frequently recorded in many studies. Indeed, Montonen et al. (1993) 
reported that the symptoms of 75% of the treated cases recurred, especially mild pain, 
Vincent’s symptom and swelling of the soft tissue. Sudden deafness, an extremely rare 
complication of non-bacterial OM localised in the temporomandibular joints (TMJ), has 
also been reported (Marsot-Dupuch, Doyen, Grauer, & de Givry, 1999). 
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1.5.3 Diagnostic imaging 
As previously mentioned, the diagnosis of the acute as well as chronic 
osteomyelitis should not depend only on clinical features, physical examination or 
laboratory findings, but also on radiological examination, an x-ray should always be 
performed when OM is suspected (Khanna et al., 2009). Diagnostic radiological imaging 
plays a vital role in differentiating OM from other diseases with similar features, such as 
tumours and fractures (Lalam, Cassar-Pullicino, & Tins, 2007). 
Several radiological techniques, including conventional radiograph, cone beam 
computed tomography (CBCT), computed tomography (CT), skeletal scintigraphy and 
magnetic resonance imaging (MRI), can be used to assist in confirming a diagnosis of 
OM, recognising the source of the infection, detecting the extensions and localisation of 
the lesions as well as verifying the involvement of the soft tissue around the lesions 
(Boeddinghaus & Whyte, 2017; Harik & Smeltzer, 2010). The use of ultrasonography 
to detect signs of change in the bone marrow is not enough to reach a diagnosis of OM, 
but rather the detection of indirect signals, such as changes of the surrounding soft 
tissues, should be used to verify the diagnosis (Bohndorf, 2004). 
Conventional radiology 
The orthopantomogram (OPT), or dental panoramic tomography (DPT), is 
considered to be the gold standard imaging tool. It offers a clear view of the maxilla, 
mandible, and the TMJ simultaneously and in one plane. OPT advantages of being 
affordable and readily available in most dental clinics and institutions add to its 
superiority. Nowadays, most panoramic devices are digital, producing a good overview 
at a low effective dose of 4.7 to 6.2 µSv (Gijbels et al., 2005; Ludlow, Davies-Ludlow, 
& Brooks, 2003). The older analogue types require a markedly higher dose, ranging 
between 16 and 26 µSv (Visser, Hermann, Bredemeier, & Kohler, 2000). Conventional 
imaging techniques are sometimes required to clarify some anatomical regions, such as 
the posteroanterior (PA) view, bilateral oblique views, Towne view, and water view. 
In the case of chronic OM, conventional radiology shows the sequester as a 
radiopaque mass, surrounded by blurry, ill-defined osteolytic frame (Ehrenfeld, 2000; 
Schimming, 2003). It has been stated that the radiographic changes are seen only after 
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the loss of 30-50% of inorganic bone substance. For this reason, it takes at least 10-14 
days from the onset of the disease for the first radiological sign to appear, since the 
newly formed bone requires a period of about 10 days, and the massive sclerotised bone 
needs 30 days to develop (Korner, Kreusch, Bohuslavizki, Brinkmann, & Kohnlein, 
1997). Due to the fact that the discernibility of the disease with the use of OPT requires 
consequential changes in the mineral content of the bone, found only in chronic OM 
(Epstein, Rea, Wong, Spinelli, & Stevenson-Moore, 1987), MRI should be used in the 
diagnosis of early stages of OM, due to its ability to detect soft tissue changes as well as 
the bone oedema (McQueen, Lassere, & Ostergaard, 2006). 
The limitation of the conventional radiology by demonstrating periosteal new 
bone deposition and bone destruction as an osteolytic and osteosclerotic lesions only, 
gives rise to the challenge of being able to differentiate between OM and its types from 
an inflammatory process caused by a neoplasm (Khanna et al., 2009). Radiological signs 
in the conventional radiology can be used to differentiate between bacterial and non-
bacterial OM (M. M. Baltensperger et al., 2009). Destruction of the cortical bone with 
sequester formation, the presence of pathological fractures, densified periosteal 
reaction, as well as an increased radiolucency (in acute disease) or an increased radio-
opacity (in chronic disease) are all signs associated with bacterial OM. In contrast, non-
bacterial OM is characterised by infrequent periosteal reaction, small radiolucent spots, 
as well as TMJ involvement. 
Computed tomography (CT) 
Computed tomography CT was invented and introduced into medical field in 
1973, as an x-ray method utilising ionizing radiation (Hounsfield, 1980). Also known as 
cross sectional imaging, CT can impressively confirm the destruction of bone structure, 
show calcified periosteal reactions, and detect sequester, one of most important 
indications of a CT scan (Sitzmann, 2003b). CT scan does not allow the 
superimposition of anatomical structures. It also aides in the easy recognition of bony 
lesions more than an orthopantomogram. The presence of soft tissue inflammation can 
be observed, but a higher dosage of radiation is required (Sitzmann, 2003b; Spitzer, 
1997). The effective dose of the CT scan needed for the mandible is about 480 µSv, 
while that for the maxilla is 580 µSv (Mah, Danforth, Bumann, & Hatcher, 2003). 
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Cone beam computed tomography (CBCT) has recently become one of the most 
reliable three-dimensions (3D) imaging technique in dentistry, acting as another option 
for the use of CT, especially in the head and neck area (Sukovic, 2003). The main 
advantage of CBCT over CT is the diminished effective dose of radiation, which is 
markedly lowered to almost 19.9 µSv for the maxilla and 34.7 µSv for the mandible 
(Akinmoladun, Akintububo, Adisa, Ojo, & Ayuba, 2013; Mah et al., 2003; Yu et al., 
2009). Reduced image quality caused by artefacts generated by metal dental fillings, 
such as amalgam, is considered a disadvantage of both CT and CBCT.  
In addition to the above mentioned radiological characteristics, CT-scans further 
aid in distinguishing between both disease entities (M. M. Baltensperger et al., 2009). 
Fistula and abscess formation, the presence of small areas of bone sclerosis with 
increased bone density, as well as demineralisation and erosion of the cortical plate are 
all observed in the acute phase of bacterial OM, while cortical plate thickening is 
usually observed in the chronic phase of the disease. Non-bacterial OM is marked by an 
increase in the size of the mandible, the presence of small osteolytic spots indicating 
infectious lacunae, destruction of the bone trabecular structure, mild bone growth, in 
addition to the infrequent finding of periosteal reaction. 
Magnetic resonance imaging (MRI)  
MRI is a highly sensitive and simultaneous non-invasive imaging technique, with 
no emission of radiation (Chung et al., 2002). It is considered as the imaging method of 
choice for the diagnosis and follow-up of OM and its progress (Jurik, 2004; Jurik & 
Egund, 1997). The ability to show high tissue contrast and great anatomical resolution 
in all three planes, coronal, axial and sagittal, are the main advantages of MRI 
(Bachmann, Jurgensen, Leiers, & Rauber, 1996). The accuracy of MRI in diagnosing 
acute OM reaches up to 94%, while it ranges from 80-100% in chronic cases (Spitzer, 
1997). By excluding characteristics of bacterial OM, such as marrow infiltration, 
sequestration, abscess, and fistula, the MRI is able to differentiate between the two 
types of OM (Robertson & Hickling, 2001). 
MRI imaging with contrast agent administration, such as gadolinium, can be used 
to detect atypical bone morrow features, cortical bone destruction (Yoshioka et al., 
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2000), as well as the degree of periosteal inflammation (Zebedin et al., 1998; Reinert et 
al., 1995) characterised by its thickness (Schuknecht, Carls, Valavanis, & Sailer, 1997). 
The lesions shown by MRI are larger than those detected by CT and scintigraphy 
(Reinert et al., 1995). In cases of infants and young children, sedation or general 
anaesthesia may be necessary. Evaluation of the extent of bone destruction or in cases 
where MRI is contraindicated, for example by uncooperative patients, the use of CT 
recommended (Karmazyn, 2010). 
Skeletal scintigraphy (bone scan) 
Bone scintigraphy is one of the most frequently performed diagnostic imaging 
techniques used in the evaluation of numerous pathologic disorders, including types and 
locations of inflammatory bone diseases, like osteomyelitis, primary bone cancers as well as 
metastasis, and some fractures not visible with the use of conventional radiology (Bahk, 
2013). 
Skeletal scintigraphy has a high sensitivity, reaching up to 95% in cases of acute 
osteomyelitis, but has a low specificity (Glaser et al., 1997). Bony pathological changes 
are detected earlier than in conventional imaging, since the blood flow and the 
osteoblastic activity reflect the process of new bone formation (Alexander, 1976). 
Approximately 15-25% of patients with metastases have normal findings with 
conventional radiology, but abnormal scintigrams, which can also detect diseases in 
their earliest stages (McDougall, 1979). 
Scintigraphy is achieved by injecting a small amount of radioactive labelled 
substance intravenously, known as radioactive tracer, such as technetium-99m–labelled 
diphosphonates, followed by image implementation after 2-4 hours (Love, Din, Tomas, 
Kalapparambath, & Palestro, 2003). Superimposition of soft tissues, a disadvantage of 
skeletal scintigraphy, can be overcome using single photon emission computerised 
tomography (SPECT) (Bachmann et al., 1996). 
1.5.4 Laboratory diagnostics 
A blood test specific for osteomyelitis has not yet been developed. In the case of 
active OM, as in almost all inflammatory diseases, the ESR may be elevated. This test, used 
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together with other non-specific tests such as CRP, is used only to confirm the presence of 
an inflammatory process, but it does not provide accurate information about the localisation 
or the cause of inflammation. CRP helps in evaluating the response to the therapy 
implemented, and checking the outcome of the treatment (Fritz & McDonald, 2008).  
1.6 Treatment of osteomyelitis  
Due to the complex nature of OM, a wide range of management protocols 
depending on several factors, such as type, aetiology of the disease, general health of 
the patient, and the presence of infected soft tissue and/or exposed jaw bones, can be 
implemented. Consequently, surgeons face a great challenge managing OM cases. The 
ablility to succeed in reaching a correct diagnosis and controlling any underlying 
diseases are pivitol in tackling the OM problem. Optimisation of systemic and 
aetiological factors, such as maintaing normal blood sugar levels, renal and hepatic 
functions, as well as stabilising fractures if present, in addition to quitting smoking and 
alcohol, are vital to the management of the disease. Patient cooperation is also necessary 
due to the long treatment process (Schimming, 2003). 
1.6.1 Bacterial osteomyelitis (B-OM) 
Eliminating the causative bacteria, preventing the spread of infection, and if possible, 
promoting the regeneration of hard and soft tissues, are the main goals of OM therapy 
(Schilli, 1988). Treatment of acute and chronic bacterial OM are mainly divided into 
conservative and surgical intervention. Conservative treatment options are always 
recommended in cases of early and simple lesions, including improvment of oral care, local 
irrigation, antibiotic therapy, photodynamic therapy (PDT), and hyperbaric oxygen (HBO). 
Antibiotic management 
Antimicrobial therapy, including bacteriostatic and bactericidal effects of the 
antibiotics, is regulary used to prevent and treat bacterial infection in acute and chronic 
osteomyelitis. Antibiotics should be started early and may be changed after results of an 
antibiotic sensitivity test. Amoxicillin/clavulanic acid is usually used initially, due to its 
wide spectrum against gram-positive bacteria such as Staphylococcus aureus , 
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Streptococcus and Clostridium, as well as gram-negative bacteria, like enterobacterial 
infection (Shah, Ramola, & Nautiyal, 2016). 
Most antibiotics used are considered as an adjuvant therapy and will normally lead to 
healing associated with neovascularisation, due to the fact that the local blood flow is 
essential for successful outcomes (Mader, Cripps, & Calhoun, 1999).  
Antimicrobial photodynamic therapy (PDT)  
Antimicrobial photodynamic therapy (PDT) was introduced in the medical field in 
the last century. The concept of this so-called laser therapy is killing microorganisms by 
applying harmless dyes or a photosensitiser (PS) combined with gentle visible light in 
an oxygenated medium. The use of photodynamic therapy is beneficial in OM patients 
suffering from other comorbidities, as it helps to reduce the use of antibiotic therapy, 
whose long-term usage can be harmful due to the side effects. However, photodynamic 
antimicrobial chemotherapy is still considered as an adjuvant therapy and not an 
alternative for the antibiotical therapy in the treatment of OM (Kharkwal, Sharma, 
Huang, Dai, & Hamblin, 2011; Rajesh, Koshi, Philip, & Mohan, 2011) (Figure 1). 
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Figure 1:  Surgical debridement of an osteomyelitis lesion, and disinfecting the 
lesion using the antimicrobial photodynamic therapy (PDT) . 
1: Exploration of an osteomyelitis lesion in the mandible through an extra-oral 
approach, 2,3: exposing the isolated sequester, which has been sent to histopathology 
for further examination, 4: Debridement of the area using a round bur, 5, 6: followed by 
disinfection using antimicrobial photodynamic therapy (PDT). 
  
1 
3 4 
5 6 
2 
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Hyperbaric oxygen therapy 
Hyperbaric oxygen therapy (HBO) is a systemic treatment option which enhances 
healing of infected and necrotic tissues by decreasing the associated hypoxia. This is 
achieved by exposing the patient to 100% oxygen in several sessions within a closed 
pressurised room. The chamber should be used for single patient or a multiplace room 
can be used for the treatment of several patients at the same time (Grime & Bryson, 
2001; Moen & Stuhr, 2012). 
HBO acts by increasing the dissolved oxygen level in the blood, which stimulates 
angiogenesis and capillary formation, helping to inactivate fibroblasts and macrophages 
(Beehner MR, 1983), in addition to having bacteriostatic and bactericidal effects 
(Mader, Adams, Wallace, & Calhoun, 1990). For these reasons, it is considered a good 
adjuvant therapy for osteomyelitis, and will only help when combined with proper 
management. HBO is usually implemented pre and post-surgically for OM patients by 
using a pressure of 2.4 x 10^5 pascal for 1 or 2 hours daily (Ehrenfeld, 2000; Fang, 
2009; Schimming, 2003). 
A study by Chin-En Chen on 14 patients suffering from refractory chronic 
osteomyelitis treated with HBO combined with surgical and antibiotic treatments, 
revealed a high rate of success (79%), with 11 of the 14 patients showing no recurrence 
of the infection. In addition, they reported no HBO related complications (C. E. Chen, 
Shih, Fu, Wang, & Wang, 2003). 
In addition to the management of OM, HBO is used widely in the field of 
dentistry. It shows promising results in the treatment of aggressive periodontitis, it is 
used as an adjuvant therapy in irradiated jaws implantology, and even in the 
management of osteoradionecrosis.  
Pregnancy, patients with uncontrolled hyperthermia, claustrophobia, upper 
respiratory tract infection and seizure disorder are cotrandications to the use of HBO 
(Devaraj & Srisakthi, 2014; Kaur, Pawar, Banerjee, & Garg, 2012). 
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Local antibiotics  
The use of local antimicrobial drugs in addition to systemic therapy has been used 
in the management of bacterial osteomyelitis, but not as a standard type of therapy for 
every case of OM (Hartley & Sanderson, 2003). The advantage of  using local 
antibiotics lies in the release of the high concentrations of antibiotics in the infected 
area. Local antibiotics, such as tobramycin or gentamicin, are used regularly after 
completing the debridement of the infected area, before wound closure. Currently, there 
are several application methods of local antibiotics, such as irrigation or the use of 
antibiotic-impregnated acrylic beads, which are removed afterwards during the surgical 
intervention, before the final reconstruction (Chisholm, Lew, & Sadasivan, 1993). 
Surgical treatment 
Despite all the above mentioned adjuvant therapies, including antibiotics, 
complete surgical removal of the diseased part of the bone still remains the mainstay 
treatment of OM (Baur et al., 2015). Surgical debridement accompanied with antibiotic 
therapy is the most common approach in the management of bacterial OM (Marx R, 
1991). The surgical treatment options range from simple incision and pus drainage to 
staged surgical debridement with reconstruction of hard and soft tissues. Complete 
removal of the bone sequester, as well as granulation and necrotic tissue, preserving the 
adjacent vital structures, help the lesion to heal properly, (Lew & Waldvogel, 2004; 
Rao, Ziran, & Lipsky, 2011), and improve the vascularisation of the remaining bone. 
The use of a healthy soft tissue graft covering the exposed bone promotes the healing 
process and gives a better outcome (Grime, Bowerman, & Weller, 1990). 
The study conducted by van Merkesteyn concluded that a bacterial OM treatment 
protocol of local debridment and marginal resection, accompained with a one-week 
parenteral antibiotic therapy followed by oral antibiotics, will lead to satisfactory results 
(van Merkesteyn et al., 1997) . In cases where excessive debridement is necessary or 
those with an underlying pathological fracture, the use of reconstruction plates or 
maxillomandibular fixation (MMF) guarantee proper stability and ensure 
immobilisation of the surgical area, which assists in proper healing. Segmental resection 
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or a mandibulectomy may be considered when extensive debridement is suspected or 
gentle debridement is not sufficient (Marx R, 1991). 
The question of the right timing for reconstructions, whether simultaneously or in 
a second stage, has been debated in the literature. Some authors recommend immediate 
reconstruction using either free autologous bone or vascularised iliac crest, while others 
report that a two staged reconstruction is safer to perform (Ioannides C, 1994; Marx R, 
1991). However, in both scenarios, the most important factor for a successful 
management of the disease remains the proper and adequate debridement of the lesion.  
Evaluation and assessment of the intra and pre operative CT or MRI as well as the 
clinical findings, such as osseous bleeding from resected margins, are necessary to 
determine and plan the extent of the mandible resection (Buchbinder & St Hilaire, 2006; 
Suh et al., 2010). Other techniques include intraoperative tetracycline bone fluorescence 
(Otto et al., 2016; Ristow et al., 2017) (Figure 2). 
  
Figure 2: Surgical debridement of the lower jaw using tetracycline bone fluorescence.  
1.6.2 Non-bacterial osteomyelitis (NB-OM) 
The precise management of non-bacterial OM has still not been formulated 
(Eleftheriou et al., 2010). However, nonsteroidal anti-inflammatory drugs (NSAIDs) 
and analgesic therapy are the most common medications used as a first-line therapy, 
which reduce the symptoms of the disease, as well as steroidal medications, which are 
also very helpful in relieving pain and swelling, especially when the NSAIDs are 
ineffective (Eyrich et al., 1999). Therefore, early diagnosis and differentiation of 
osteomyelitis will save patients useless and sometimes even harmful surgical 
interventions, as well as ineffective long-term antibiotic treatment.  
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Even though many studies revealed that long-term antibiotic therapy has no effect 
on the progression of NB-OM (A. Jansson, Golla, Schneider, Jansson, & Belohradsky, 
2002; Schilling, 1998; van Merkesteyn, Groot, Bras, McCarroll, & Bakker, 1990), HBO 
promotes blood perfusion, enhances osteogenesis and neovascularisation, and helps in 
combination with surgical decortication to increase the vascularity and decrease the 
pressure in the medullary bone, hence it is indicated in the management of some cases 
of non-bacterial OM (Jacobsson & Hollender, 1980; Montonen & Lindqvist, 2003; 
Suei, Taguchi, & Tanimoto, 1997; Van Merkesteyn, Groot, Bras, & Bakker, 1988). 
Nonetheless, all the previously discussed treatment protocols are generally 
unsatisfactory and will not lead to longlasting elimination of symptoms like continued 
pain, trismus and inflammation (Groot, van Merkesteyn, van Soest, & Bras, 1992; 
Kuijpers et al., 2011; Van Merkesteyn et al., 1988). Consequently, the use of 
corticosteroids, tumor necrosis factor-alpha (TNF-α) inhibitors, and also 
bisphosphonates are reported. 
In the last 20 years, several articles have been published discussing the treatment 
of NB-OM with different kinds of bisphosphonates, whether it requires nitrogen or not 
and whether it should be applied intravenously or orally (Montonen et al., 2001); 
(Compeyrot-Lacassagne, Rosenberg, Babyn, & Laxer, 2007; Hino et al., 2005; Kuijpers 
et al., 2011; Soubrier, Dubost, Ristori, Sauvezie, & Bussiere, 2001; Sugata, Fujita, 
Myoken, & Kiriyama, 2003; Yamazaki et al., 2007). The efficiency of bisphosphonates 
in treating NB-OM offers an overview into the possible underlying pathophysiology. 
Clinical and radiological features, characterised by new bone deposition and resorption 
occurring in a random manner, as well as the bisphosphonates mode of action, indicate 
that osteoclastic activity and osteoclast/osteoblast imbalance, affecting osteogenesis and 
osteolysis, has an important part in disease development (Otto et al., 2015). 
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1.7 Differential Diagnosis 
The aim of this study is to differentiate between bacterial and non-bacterial types 
of osteomyelitis, with the latter being considered an important differential diagnosis for 
acute and secondary chronic OM (A. F. Jansson et al., 2009). Primary malignant bone 
tumours, as well as metastases, commonly orginate from the prostate, kidney, lung, or 
breast cancers, in addition to tumour-like lesions, such as fibrous dysplasia, medication 
related osteonecrosis of the jaw (MRONJ), osteoradionecrosis (ORN), and ossifying 
fibroma are also important differential diagnostic considerations. Proper clinical, 
radiological and histopathological examinations can easily lead to definitive diagnosis 
of osteomyelitis. Therefore, harvesting biopsy specimens is necessary to distinguish and 
confirm the diagnosis (Eyrich et al., 2003; M. Baltensperger et al., 2004; Stern & 
Ferguson, 2013). 
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2. Purpose of the Study 
Despite a large number of proposed classification systems for osteomyelitis, and 
the many definitions of osteomyelitis in the literature, no comprehensive nomenclature 
has been formulated and internationally acknowledged. Therefore, clinicians could not 
until now, follow universal guidelines regarding this disease. 
The aim of the study was to demonstrate our clinical experience with 
osteomyelitis of the jaw and differentiate between bacterial and diffuse sclerosing OM 
in terms of clinical, pathological, radiographic and microbiological findings with the 
treatment strategy of each type of OM. 
The specific objectives were to:  
1. Identify a suitable patient cohort 
2. Examine the above mentioned parameters retrospectively 
3. Tabulate these parameters and unveil similarities  
4. Investigate potential factors linked to the occurrence of OM of the jaw 
5. Identify risk factors associated with OM 
6. Develop a comparison between the types of OM based on etiological factors of 
osteomyelitis 
7. Document the treatment methods of patients. 
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3. Patients and Methods 
3.1 Study design and sample selection 
This retrospective cohort study screened and analysed the medical records of 
patients with bone lesions who had been admitted to the Oral and Maxillofacial Surgery 
Department, Ludwig-Maximilians-University, Munich, Germany from 4th January 
2003 to 30th December 2012, according to STROBE (Strengthening the Reporting of 
Observational studies in Epidemiology). 
Inclusion criteria: patients with a clinically and radiologically confirmed diagnosis 
of osteomyelitis who had received conservative or surgical treatment. 
Exclusion criteria: patients with a history of radiation to the head and neck region 
or if they had received antiresorptive drugs prior to the diagnosis of osteomyelitis 
(bisphosphonates or denosumab), either orally or intravenously. 
3.2 Study variables 
Data were gathered from the institution’s archive by screening patients’ records 
such as medical files, clinical photos, radiographs and operational reports. 
The extracted data included: 
• Demographic data (age, gender) 
• Health issues and behavioural habits such as alcohol and alcohol consumption 
• Underlying diseases 
• Comorbidities and medications 
• Risk factors 
• Clinical findings 
• Location of the lesion 
• Radiological findings (panoramic radiograph OPT and/or cone beam CT and/or 
magnet resonance imaging) 
• Information about their treatment  
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3.3 Ethics 
The study design was reviewed and approved by the ethical committee of the 
medical faculty, Ludwig-Maximilians-University (Project-Nr. 083-11). The patient data 
was anonymous; none of the patients were submitted to any experimental trial of any 
kind. The need for patient informed consent was waived given the retrospective nature 
of the study. 
3.4 Treatment protocol  
Treatment was provided based on the treatment classification of the German 
Association of Oral and Maxillofacial surgery DGMKG (AWMF online, stand 2008). 
Conservative treatment consisted of irrigation and systemic antibiotics 
(amoxicillin/clavulanic acid 875/125 twice daily, or clindamycin 600 mg three times 
daily); some cases were treated with photodynamic therapy and hyperbaric oxygen 
therapy. Surgical treatment included incision and drainage, curettage, sequestrectomy, 
debridement of the necrotic bone, decortications, local application of antibiotics, 
extraction of causative teeth, splinting of movable teeth, microvascular reconstruction 
and fracture stabilisation. 
3.5 Data analysis	
The data were tabulated in Microsoft Excel (Microsoft, Redmond WA, USA) and 
were analysed with SPSS statistical software (SPSS Statistics Version 20, IBM). 
Descriptive and inferential statistics were computed with respect to the variable scale. 
Fisher’s exact test with Chi-square test were applied and results were written down in 
mean values and in percentages, standard errors of range and mean were included. The 
significance level was set at p < 0.05. 
  
Results 27 
 
 
4. Results 
The medical records of 175 patients who had been admitted to the Oral and 
Maxillofacial Surgery Department were screened, of which, a total of 67 patients 
diagnosed with OM were included in this study. Among them, 52 patients were 
suffering from B-OM and 15 from NB-OM (DSO). Figure 3 shows the percentage of 
the two types of OM. 
 
Figure 3: Flowchart of number of patients in the study. 
Data were classified according to the following categories: age, sex, location of 
the lesion, distribution of the disease, comorbidities and medications, behavioural risk 
factors, clinical presentation, radiographic features and treatment. 
  
67	patients	
met	our	inclusion	
criteria
175	suffered	
from	
osteomyelitis	
B-OM	
52	=	78%
NB-OM
15	=	22%
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4.1 Age and sex 
The study sample consisted of 67 patients. The mean age of the patients 
diagnosed with OM was 51.8 years, with B-OM patients having a mean age of 55.4 ± 
19.5 years. In general, the majority of patients were female (40 of the 67 patients; 
59.7%). There was a female predilection in the ratio of 4:1 in NB-OM, however, the 
ratio of females to males was close to 1:1 for B-OM. 
4.2 Location of the lesion	
The mandible was the most affected site in B-OM (88.5%) and NB-OM (100%), 
whereas NB-OM was never present in the maxilla, but exclusively related to the 
mandible. One patient had the lesion in both jaws for B-OM (1.9%). Table 1 
summarises the demographic data of both B-OM and NB-OM. 
Table 1:  Descriptive statistics and results of the comparison of the demographic 
data of both groups of osteomyelitis 
Characteristics Bacterial 
(n = 52) 
Non-Bacterial 
(n = 15) 
P-value 
n (%) n (%)  
Gender     
 Male 24(46.2) 3(20.0) 0.069 
 Female 28(53.8) 12(80.0) 
Age      
 ≤30 6(11.5) 5(35.7) 
0.217 
 31 - 40 5(9.6) 2(14.3) 
 41 - 50 8(15.4) 3(21.4) 
 51 – 60 10(19.2) 2(14.3) 
 61 – 70 12(23.1) 0(0) 
 71 – 80 8(15.4) 1(7.1) 
 ≥81 3(5.8) 1(7.1) 
Location     
 Maxilla 5(9.6) 0(0) 0.806 
 Mandible 46(88.5) 14(93.3) 
 Both 1(1.9) 0(0) 
*: significant at P ≤ 0.05 
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4.3 Distribution of the disease 	
The distribution of the necrotic lesions was symmetric, with osteomyelitis 
occurring in the right side of the jaw accounting for 41.6% of the cases. The same result 
was observed for cases in the left side of the jaw (41.6%). In the remaining 14.9% of 
cases, both sides of the jaw were affected. Figure 4 shows an accurate description of 
affected areas (using the International dental scheme of FDI World Dental Federation). 
 
Figure 4:  Distribution of osteomyelitis in the oral cavity based on the International 
Dental Scheme (FDI). Panel (A): Bacterial osteomyelitis (B-OM) and 
(B): Non-bacterial osteomyelitis (NB-OM; Diffuse sclerosing 
osteomyelitis of the jaw). 
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4.4 Comorbidities and medications	
Based on patients’ records, 6 of the 67 patients (5 patients with B-OM and 1 with 
NB-OM) were diagnosed with diabetes mellitus. Fifteen patients (28%) with B-OM had 
a history of hypertension, while 4 patients (28%) were hypertensive in NB-OM. 
Osteoporosis was observed in (5.8%) of patients with B-OM and in one patient (7.1%) 
of patients with NB-OM (without antiresorptive treatment). Six patients (11.5%) with 
B-OM suffered from malignant underlying disease, without been treated with radiation, 
bisphosphonate or denosumab, whereas no cases of such diseases were reported in 
patients with NB-OM (Table 2). 
With regard to the relevant medications, 4 patients (7.7%) with B-OM and 2 
patients (14.3%) with NB-OM had a history of steroid intake. Three patients from the 
bacterial type (5.8%) were treated with immunosuppressives and no record of 
immunosuppressive treatment in NB-OM patients was observed (Table 2). 
4.5 Risk factors	
The most common preceding event to B-OM was dentoalveolar surgery (42.3%), 
while it was tooth extraction for NB-OM (33.3%) (Table 2). Mandibular fracture was 
also identified as a risk factor for the development of B-OM (17.3%). The most frequent 
behavioural risk factor associated with OM was smoking (B-OM: 18 patients, 34.6%; 
NB-OM: 4 patients, 30.8%), followed by alcohol abuse (B-OM: 13 patients, 25%). 
When comparing the two types of OM, the difference between smoking habits in B-OM 
and NB-OM was statistically insignificant between the two groups. However, for heavy 
alcohol consumption, the B-OM group showed a statistically significantly higher 
prevalence than the NB-OM group (Table 2). 
 
4.6 Clinical presentation	
An overview of the signs and symptoms for both types of OM reported pain as the 
most frequent symptom in 92.3% of cases with B-OM and in all cases of NB-OM, 
while the most common clinical finding was swelling, observed in 84.6% of patients 
with B-OM and 80.0% of patients with NB-OM. Inflammation was also a common 
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symptom in B-OM. Intra-oral fistulas were only apparent in B-OM in 26.9% of the 
cases. The majority of wound healing disturbances was recorded in 28.8% of B-OM 
group and in only 6.7% of the NB-OM group (Table 2). 
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• Table 2:  Descriptive statistics and results of comorbidities, triggering factors 
and treatment in the two groups of osteomyelitis 
 
Bacterial 
(n = 52) 
Non-Bacterial 
(n = 15) P-value 
n (%) n (%) 
Comorbidities    
Diabetes 5(9.6) 1(6.7) 1.000 
Osteoporosis 3(5.8) 1(6.7) 1.000 
Hypertension 15(28.8) 4(26.7) 1.000 
Malignant underlying disease 6(11.5) 0(0.0) 0.325 
Smoking 18(34.6) 4(26.7) 0.757 
Alcohol 13(25.0) 0(0.0) 0.031* 
Steroids 4(7.7) 2(13.3) 0.609 
Immunosuppressives 3(5.8) 0(0.0) 1.000 
Preceding events    
     Tooth extraction 8(15.4) 5(33.3) 0.146 
Impacted wisdom tooth 1(1.9) 0(0.0) 1.000 
DA-surgery  22(42.3) 4(26.7) 0.273 
Periodontitis 6(11.5) 2(13.3) 1.000 
Fracture** 9(17.3) 0(0.0) 0.191 
Unknown 6(11.5) 3(20.0) 0.407 
Signs and symptoms    
Pain 48(92.3) 15(100.0) 0.568 
Wound healing disturbance 15(28.8) 1(6.7) 0.095 
Swelling 44(84.6) 12(80.0) 0.699 
Extra-oral fistula 12(23.1) 0(0.0) 0.055 
Intra-oral fistula 14(26.9) 0(0.0) 0.028* 
Sensibility disorder 4(7.7) 1(6.7) 1.000 
Exposed bone 3(5.8) 0(0.0) 1.000 
Pathological fracture 5(9.6) 0(0.0) 0.580 
Treatment    
Conservative 2(3.8) 15(100.0) <0.001* 
Surgical 50(96.2) 2(13.3) <0.001* 
Treatment modalities of B-OM    
Antibiotics 51(98.1) 8(53.3) <0.001* 
Irrigation 10(19.2) 1(6.7) 0.433 
PDT 6(11.5) 0(0.0) 0.325 
HBOT 1(1.9) 1(6.7) 0.400 
Bisphosphonate 0(0.0) 9(60.0) <0.001* 
I&D 16(30.8) 3(20.0) 0.527 
Curettage 10(19.2) 0(0.0) 0.101 
Sequestrectomy 25(48.1) 0(0.0) 0.001* 
Debridement 13(25.0) 0(0.0) 0.031* 
Decortication 13(25.0) 2(13.3) 0.490 
Local application of AB 4(7.7) 0(0.0) 0.568 
Extraction of causative teeth 13(25.0) 1(6.7) 0.164 
Continuity resection 1(1.9) 0(0.0) 1.000 
Plastic reconstruction 2(3.8) 0(0.0) 1.000 
Fracture treatment & prevention: 16(30.8) 0(0.0) 0.014* 
Reduction & osteosynthesis 9(17.3) 0(0.0) 0.191 
Re-osteosynthesis 5(9.6) 0(0.0) 0.580 
Protection plates 2(3.8) 0(0.0) 1.000 
*: significant at P ≤ 0.05 
**: Only 9 from the 14 fracture-treated case were triggered by the fracture itself, the other 5 cases 
were submitted under other proceeding events as the fracture was not the direct trigger. 
Results 33 
 
 
***:  Fracture treatment & prevention include not only the cases admitted to our clinic with fractures 
leading to OM but also the cases with inadequate treated fractures or unsuccessful inserted 
osteosynthesis needing re-osteosynthesis and cases with weakness or defect in jaw needing fracture 
prevention using protection plates 
 
1.1 Radiographic features	
Radiographic examination revealed the presence of irregular radiolucency and 
resorption of surrounding bone (sequester formation) in cases of fracture bone 
destruction and necrosis adjacent to the fracture site in B-OM, while NB-OM showed 
multiple radiolucent and radiopaque mass in the affected area of the mandible and 
appeared to be unattached to the root apices. 
 
Figure 5:  Clinical and radiographic presentation of bacterial (B-OM) and DSO of 
the jaw.  
Panel (A) B-OM: Patient presented with extra-oral swelling of the left side of the face, 
trismus, signs of inflammation, fistula formation, pus discharge, palpable 
lymphadenopathy and scar formation. The lesion was related to the mandible with 
exposed necrotic bone involving the mylohyoid ridge intra-orally. Panoramic 
radiograph showed osteolytic changes observed at the fracture site related to the body of 
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the mandible. Panel (B) NB-OM (DSO): Patient presented with facial asymmetry and 
indurated hard swelling in the right side of the face without suppuration and cervical 
lymphadenopathy extra-orally. Intra-orally, the patient had normal intact mucosa 
without any lesions. Panoramic radiograph showed diffuse radiopaque and radiolucent 
alveolar bone changes in the body of the mandible related to the right molar region. 
 
1.2 Treatment 
When comparing management performed for both B-OM and NB-OM, surgical 
procedures were frequently used in the treatment of the B-OM group (50 cases; 96.2%); 
this was significantly higher than for the NB-OM group (4 cases; 26.7%). The main 
surgical procedures included incision and drainage, sequestrectomy and surgical 
removal of necrotic bone. In particular, sequestrectomy was frequently performed in the 
B-OM (25 cases; 48.1%). Furthermore, systemic antibiotic usage was significantly 
higher in B-OM (51 cases; 98.1%) compared to NB-OM (8 cases; 53.3%), the latter 
being mainly a diagnostic measurement in order to rule out B-OM. The bisphosphonate 
intake between the two groups was statistically significant. In NB-OM, bisphosphonate 
was administrated for 9 cases out of 15 (60%), whereas it was not used at all in the B-
OM (Table 2). 
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Supplementary Table 1: Classification and clinical picture of OM 
 Bacterial osteomyelitis Non-bacterial osteomyelitis 
Clinical findings pain & swelling pain & swelling 
 abscess formation and 
suppuration 
no abscess formation, no 
suppuration 
Radiographic 
features 
osteolytic pattern 
formation of sequester 
mixed pattern  
resorption and/or enlargement of 
external bone 
Histologic findings necrotic changes and 
inflammation of bone 
Formation of abscesses and 
sequester 
inflammation changes of bone 
reactive hyperplasia of bone  
similarity changes to fibrous 
dysplasia 
Medication antibiotic anti-inflammatory drugs such as 
corticosteroids & bisphosphonate 
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2. Discussion 	
The purpose of the study was to draw on our experience with osteomyelitis to 
differentiate non-infectious osteomyelitis of the jaw as non-bacterial osteomyelitis from 
the bacterial type, highlighting some of the most important features in addition to the 
management of both types of OM. 
Osteomyelitis is frequent in the facial area and its characteristics include 
malfunction, progressive inflammatory destruction, marked bone absorption in the 
affected area and atypical bone remodelling. The disease may lead to complications 
after orthopaedic and maxillofacial surgeries or small surgical interventions like teeth 
extractions (Fliefel et al., 2016). There are multiple reasons for osteomyelitis such as 
medications, radiation, odontogenic sources, trauma and in some cases, the cause 
remains unknown (Hong et al., 2016). 
The disease is classified as acute until one month of clinical duration and chronic 
when it lasts longer (Hudson, 1993).  Authors have classified chronic osteomyelitis into 
suppurative or non-suppurative recurrent multifocal and sclerosing, differentiating 
between the three classifications of acute osteomyelitis, contiguous focus, 
haematogenous type and progressive type (Miloro, Ghali, Larsen, & Waite, 2004). 
Currently, more common osteomyelitis variants are regarded as chronic non-
suppurative osteomyelitis of the mandible, referred to as primary chronic osteomyelitis 
(PCO), diffuse sclerosing osteomyelitis (DSO) and juvenile mandibular chronic 
osteomyelitis (JMCO) in the oral and maxillofacial surgical literature. Variable 
terminology has caused confusion and hampered understanding of the disease process 
(Renapurkar, Pasternack, Nielsen, & Kaban, 2016).  
Similar to previous studies, the most common symptom in B-OM was local pain, 
as reported in 94% of the cases (Catalano-Pons et al., 2008; Gikas et al., 2009; A. 
Jansson et al., 2007; Spindler, Huenges, & Hoppe, 1998). Other common findings, such 
as swelling, fistula, sequestrations and inflammation, also correlated with earlier studies 
for OM of the jaw (Prasad, Prasad, Mouli, & Agarwal, 2007). Fistula was present in 
more than one third of the patients, similar to that reported in other studies (Baur et al., 
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2015; Taher, 1993). Clinical signs of inflammation due to the increased blood flow to 
the inflamed area were noted, especially in the bacterial group as described previously 
(Dietz, Bachmeyr, & Joppich, 2004; Spindler et al., 1998; Voit, 2013). 
In the study of Baur et al. (Baur et al., 2015), anaesthesia of the lower lip because 
of the affected inferior alveolar nerve was evident in 29.1% of patients. In the present 
study, this finding was evident in only 7.5% of all patients. This difference is accredited 
to the fact that the cases in our study were acute and chronic OM, compared with only 
chronic cases in Baur’s study. 
With regard to the present study’s demographic findings, the majority of patients 
were female in both B-OM and NB-OM. This was in accordance with a review of 260 
cases which found that females are four times more affected than males in NB-OM 
(Beretta-Piccoli et al., 2000). The median age of NB-OM was 9 years as reported in many 
studies (Job-Deslandre, Krebs, & Kahan, 2001; Jurik & Egund, 1997; Monsour & Dalton, 
2010). When comparing the age prevalence between B-OM and NB-OM of patients, B-
OM had a wider range of age compared to NB-OM. It presented in all age groups, which 
correlates with several previous studies and may be related to the systemic comorbidities 
and dental complications (Baur et al., 2015; Bevin, Inwards, & Keller, 2008; L. Chen et 
al., 2013; Tanaka & Hayashi, 2008). The onset of NB-OM was recorded in this present 
study, like in several others, mostly in adolescents and young adults (Bjorksten, 
Gustavson, Eriksson, Lindholm, & Nordstrom, 1978; Schilling, 1998; Schilling, Eckardt, 
& Kessler, 2000; Schilling & Kessler, 2001; Seidl, Maier, Refior, & Veihelmann, 2003; 
Sundaram, McDonald, Engel, Rotman, & Siegfried, 1996; Uhl M, 1995). Primary chronic 
osteomyelitis has been reported in children of both sexes, with a peak onset between 10 
and 20 years (Gentry, 1988). 
In the majority of the patients in our case series, the lesions were located in the 
mandible, with pain and swelling the most reported clinical findings, while the maxilla 
was rarely affected by OM due to the good blood supply of the maxilla and its unique 
spongy feature (Adekeye & Cornah, 1985). This is in agreement with numerous other 
studies (Adekeye & Cornah, 1985; Chronopoulos et al., 2015; Fliefel, Troltzsch, 
Kuhnisch, Ehrenfeld, & Otto, 2015; Palla, Burian, Klecker, Fliefel, & Otto, 2016; 
Prasad et al., 2007; Taher, 1993). Even though fractures and trauma are important 
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predisposing factors of the disease, they rarely lead to osteomyelitis in the maxilla 
because of it excellent blood supply (Adekeye & Cornah, 1985). 
With all the recent antimicrobial antibiotic drugs, the propagation of OM has been 
diminished, except in medically compromised patients. Nevertheless, risk factors and 
systemic conditions play a role in OM, thus have to be well studied and managed when 
treating OM as they may alter the bone's vascularity or modify the patient’s defence, 
thereby affecting the healing process (Pincus, Armstrong, & Thaller, 2009). The most 
prominent comorbidities identified in this study were hypertension (28.4%) and 
diabetes (9%), which was in line with other reports (Baur et al., 2015). Tobacco and 
alcohol use has been shown to be associated with this disease, with no significant 
difference between the two disease entities. However, alcohol consumption was 
significantly more prevalent in B-OM compared to NB-OM. This is in accordance with 
previous studies which implicated these habits as predisposing factors for B-OM of the 
jaw (Koorbusch et al., 1992). 
The results of this study support the findings of another study of 88 cases of 
osteomyelitis of the mandible, which reported trauma as the most frequent trigger 
inducing the disease (Taher, 1993). In this study, dentoalveolar surgery was the most 
common preceding event of OM, followed by fracture. However, it needs to be 
emphasised that dentoalveolar surgery are usually caused by an infection (e.g. 
odontogenic infection leading to dental extraction). This differed from the findings of 
the Koorbusch study, which reported traumatic causes (36.1%), odontogenic infections 
(36.1%) and radiation and neoplasm (16.7%) (Koorbusch et al., 1992). Other studies 
revealed odontogenic infection to be the most predominant cause of the disease of a 
Nigerian population and that trauma-related causes had a much lower frequency 
(Akinmoladun et al., 2013). In contrast, some studies reported that traumatic and 
odontogenic causes have the same prevalence (36.1%) (Daramola & Ajagbe, 1982).  
There is a wide range of treatment protocols for OM due to its complex nature 
(Fliefel et al., 2016). The treatment was differentiated according to the aetiology of the 
disease. Almost all cases (98.1%) of the B-OM were treated with antibiotics, in 
accordance with previous studies (Darville & Jacobs, 2004; A. F. Jansson et al., 2009; 
Karmazyn, 2010; Steer & Carapetis, 2004) and in line with recommendations in the 
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literature (Darville & Jacobs, 2004; A. F. Jansson et al., 2009; Karmazyn, 2010; Steer & 
Carapetis, 2004). 
Chronic bacterial osteomyelitis also requires surgical intervention to create 
appropriate healing conditions, through the removal of the necrotic bone parts to acquire 
good, vital and vascularised surrounding tissue and through sequestrectomy and 
removal of soft and hard necrotic tissues (Lew & Waldvogel, 2004; Rao et al., 2011). In 
total, 96.2% of the patients included in this study had undergone removal of necrotic 
bone parts, whereas resection of jaw continuity took place in only 1.5% of patients. 
However, other studies on OM showed the use of antimicrobial therapy as a 
conservative treatment (Koorbusch et al. (1992). 
Antibiotic therapy should start early during the treatment and continue post-
operatively to prevent post-surgical infections (Nezafati et al., 2009). Antibiotics can be 
changed according to the antibiogram (Voit, 2013). However, record audits did not 
show a pattern consistent with culture-guided antibiotic therapy, as they were 
administrated only in cases were empirical antibiotics were found to be clinically 
ineffective. The treatment of NB-OM remains controversial (Eleftheriou et al., 2010), 
although the treatment of OM has been excessively developed in the past few years due 
to new antibiotics and anti-inflammatory drugs, non-bacterial osteomyelitis of the 
mandible does not always respond to medical treatment (Hino et al., 2005). 
Some studies suggested glucocorticoid therapy in cases showing no-recovery after 
being treated with NSAIDS (Girschick et al., 1999; Girschick et al., 2005). 
Furthermore, alpha-interferon has been successful for the treatment of OM in some 
studies, but currently is not an accepted alternative for glucocorticoids (Andersson, 
1995; Otsuka, Hamakawa, Kayahara, & Tanioka, 1999). 
Despite the association between bisphosphonate intake and the occurrence of 
osteonecrosis reported repeatedly in the literature (Ärzteschaft, 2005; Carter & Goss, 
2003; Hoefert S, 2004; Migliorati, 2003; Otto et al., 2012; Schwartz, 2004), several 
studies recommend bisphosphonate for the treatment of NB-OM and in particular, for 
CRMO.  
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Other treatments reported in the literature include azithromycin, interferon, 
sulfasalazin, azathioprin, methotrexat, intravenous immoblubine or colchicin (Beck et 
al., 2010; Catalano-Pons et al., 2008; El-Shanti & Ferguson, 2007; Gikas et al., 2009; 
Huber et al., 2002; A. G. Jansson et al., 2002; A. G. Jansson et al. 2004; Schilling et al., 
2000; Wipff, Adamsbaum, Kahan, & Job-Deslandre, 2011). 
In this study, bisphosphonate and NSAIDs were the most commonly used drugs 
for the treatment of NB-OM based on the consensus recommendation of the German 
Society for Pediatric and Adolescent Rheumatology (GKJR) (A. Jansson, Jansson, & 
von Liebe, 2009; Wipff et al., 2011). Bisphosphonate was applied as an alternative 
therapy in NB-OM patients who did not respond to the treatment with NSAIDs (Otto et 
al., 2015; Seidl et al., 2003; Simm, Allen, & Zacharin, 2008). Consequently, 60% of the 
patients suffering from NB-OM were treated with an intravenous single shots of 
ibandronate as described by Otto et al. (Otto et al., 2015). 
The most common surgical interventions in the present study were 
sequestrectomy, extraction of the causative teeth and debridement of the necrotic bone. 
Other surgical interventions such as curettage and partial resection did not show any 
long-term success (A. G. Jansson et al. 2004; Voit, 2013) but were added occasionally 
when needed to the treatment. 
Even though antibiotic therapy did not have any effect on the progress of NB-OM 
in many studies (A. Jansson et al., 2002; Schilling, 1998; van Merkesteyn et al., 1990), 
53 % of patients were treated before being referred to our hospital or during our 
diagnostic phase with antibiotics. This helped in the differential diagnosis, mainly to 
exclude the bacterial type of OM; after NB-OM was diagnosed, antibiotics were 
stopped immediately. 
The typical clinical presentation of B-OM is pain, erythema and oedema of the 
affected part. This was different from NB-OM, where no existence of pus nor sinus tract 
were found (Lee, Sadigh, Mankad, Kapse, & Rajeswaran, 2016). Even though 
microbiological causes can be the initial preceding event, there are not enough studies 
to support a bacterial cause of the disease. 
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It has been reported that microbiological cultures are frequently sterile, and when 
bacterial contamination is detected, it was due to contamination of the sample by oral or 
skin flora according to whether the biopsy was transoral or extra-oral (Otto et al., 2015). 
Therefore, we suggest that the disease is named DSO, a metabolic bone disorder, rather 
than an infection. 
2.1 Limitations of the study 
The present study has several limitations. The study was retrospective, so some 
data may be missing. However, the study included much clinical information and 
patient data collected over a long period of time, and considered both types of OM. The 
study was conducted at a single-centre, multicentre studies would be useful to confirm 
the findings and to compare the data and management protocols. It is possible that the 
lack of a follow-up period may have affected the conclusion regarding disease 
management. Therefore, more studies are recommended, with a follow-up period 
applying the same treatment methods and further investigation of underlying diseases 
and their association with the incidence and prognosis of OM in both two types. 
Conclusion 42 
 
 
3. Conclusion 
Most cases of osteomyelitis in this study were of the bacterial type. The disease 
was predominantly located in the mandible, with pain, swelling and inflammation the 
most commonly reported symptoms in a patient suffering from osteomyelitis. The 
majority of cases were preceded by trauma such as dentoalveolar surgery and fractures, 
followed by odontogenic infections, in particular when associated with unhealthy 
personal habits, such as smoking tobacco and high alcohol consumption. Bacterial 
osteomyelitis (B-OM) is a true infection originating from a wide range of 
microorganisms affecting the oral structures and is initiated by triggering factors. 
However, non-bacterial osteomyelitis (NB-OM) or diffuse sclerosing osteomyelitis 
(DSO), which is another different entity of chronic bone disorders potentially 
characterised by dysregulation of coupling between bone formation and resorption. 
Thus, using the terminology of osteomyelitis might be a misleading, contributing to the 
confusion in understanding the pathogenesis of the disease. Further studies are needed 
to exclude the role of bacteria in the disease. Finally, the convenient management of 
systemic diseases and awareness of the risks of smoking and alcohol consumption can 
reduce the occurrence of osteomyelitis of the jaw.  
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Summary  
Bacterial osteomyelitis versus diffuse sclerosing osteomyelitis of the jaw, similar 
nomenclature, different disease entity 
Introduction: Osteomyelitis (OM) of the jaw is considered one of the most challenging 
problems for dental clinicians. Many classifications of OM have been developed based 
on several characteristics including the clinical progression and pathogenesis of the 
disease. A particularly informative classification discriminates between bacterial 
osteomyelitis (B-OM) and non-bacterial osteomyelitis (NB-OM), presenting as diffuse 
sclerosing osteomyelitis (DSO).  
Aim: To draw on our experience and observations of osteomyelitis of the jaw to 
differentiate between B-OM and NB-OM with respect to clinical, radiographic and 
microbiological findings, as well as discussing the treatment strategies of each type of 
OM.  
Methods: The medical records of 175 patients were screened retrospectively, of which, 
a total of 67 patients were diagnosed with OM and treated surgically or conservatively 
at a single institution between January 2003 to December 2012. Demographic-, 
anamnesis-, clinical-, and radiological data were collected and evaluated. The patients 
were allocated into two groups depending on their aetiology, clinical and radiological 
features. Patients with history of radiation and bisphosphonate intake prior to OM 
diagnosis were excluded. 
Results: The mean age of patients diagnosed with OM was 52 years and the mandible 
was the most commonly affected site. Moreover, behavioural risk, such as smoking and 
alcohol abuse, were commonly associated with OM. Notably, surgical procedures were 
significantly more frequent in the treatment of the B-OM group (50 cases; 96.2%) than 
in the treatment of the NB-OM group (4 cases; 26.7%). 
Conclusion: Diffuse sclerosing osteomyelitis is distinct to other forms of osteomyelitis 
and the use of misleading terminology to describe DSO leads to confusion and 
misunderstanding of this disease. 
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Appendix 
ERFASSUNGSBOGEN  
 
Geschlecht	 	 	 	 	 	 	 ┌	 	 	 	 										┐	
Alter	
Grunderkrankungen/Diagnosen	 	 	 	 	 	Patientenaufkleber																																																										
	
Diabetes	:	 	 	 	 	 	 	 └	 	 	 	 									┘	
	
Immunosuppression:	
	
	
Osteoporose:	
	
	
Gefäßerkrankungen:	
	
	
Allergie:     
	
	
Rauchen:			  
	
regelmäßiger	alkoholkonsum:		
																				
Maligne	Grunderkrankungen:	
	
o ggf.	Metastasen	:		
o ggf.	Chemotherapie:	
o ggf.	Bestrahlung:		
o ggf.	Bisphosphonat:	
	
Andere	Erkrankungen:	
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Medikamente:	
Steroide:	
Immunsuppressiva	medikamente:	
	
Andere	Medikamente:	
	
	
	
	
	
Typ	der	Osteomyelitis:	
Ggf.	(ED)	
Lokalisation	der	Osteomyelitis:				
o Oberkiefer		(OK):	
o Unterkiefer	(UK):		
	
Klinischen	Zeichen:											 														□ Schmerzen	
□ Wundheilungsstörung	
□ Schwellung	
	 	 	 	 	 □ Entzündung	
	 	 	 	 	 □ Zufallsbefund	
□	Extraorale	Fistel				
□ Intraorale	Fistel 		
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Therapeutischen	Maßnahmen:	
	
	
Konservative	Therapie:	
	
o Antibiotikatherapie	
o Spül/Saugdrainagen	
o Lokale	Wundpflege			(ggf.	Photodynamische	Therapie)	
	
o Hyperbare	Sauerstofftherapie	
o Bisphosphonate	applikation	
	
Operative	Therapie:	
o Inzision	&	Drainage	
o Kürettage	
o Sequestrektomie	
o Debridement	nekrotischer	Knochenanteile	
o Dekortikation	
o Evtl.	topische	Applikation	von	Antibiotika	
o Extraktion	verursachender	(avitaler)	Zähne	
o Schienung	beweglicher,	jedoch	vitaler	Zähne	
o Entfernung	nekrotischer	Knochenanteile	und	Knochenanfrischung	bis	zum	vitalen	
Knochengewebe	
o Partielle	oder	Kontinuitatsresektion	
o Plastische	Rekonstruktion	
o Frakturstabilisierung	
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									Mögliche	auslösende	Faktoren	der	Osteomyelitis	
	
Zustand	nach		 Wann?	
(Monat	und	Jahr)	
Welcher	Zahn/Zähne?		Lokalisation	
Zahn	EX	 	 	
WHZ	OPE	 	 	
WSR	 	 	
WKB	 	 	
Implantation	 	 	
												PA-Therapie	
	
												Parodontitis	apicalis	
	
												Infizierte	Zyste						
													
												Tumor	Entfernung		
	
												Fremdkörper		
													
												Fraktur	
	
	
	
Pathohistologisches	Ergebnis:		
	
			(ggf.	Einlage)	
	
Mikrobiologischer	Befund:			
	
			(ggf.	Einlage)	
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